Group One Trading, L.P. Soleno Therapeutics Inc Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.14 - $0.23 $652 - $1,072	-4,662 Reduced 46.4%	5,386 $1,000
Q1 2022 May 12, 2022	SELL	$0.22 - $0.47 $7,456 - $15,929	-33,893 Reduced 77.13%	10,048 $2,000
Q4 2021 Feb 11, 2022	BUY	$0.41 - $0.91 $12,673 - $28,129	30,911 Added 237.23%	43,941 $18,000
Q3 2021 Nov 12, 2021	SELL	$0.8 - $1.12 $4,240 - $5,936	-5,300 Reduced 28.91%	13,030 $12,000
Q2 2021 Aug 10, 2021	BUY	$0.97 - $1.32 $11,796 - $16,052	12,161 Added 197.13%	18,330 $21,000
Q1 2021 May 12, 2021	SELL	$1.24 - $3.3 $2,127 - $5,662	-1,716 Reduced 21.76%	6,169 $8,000
Q4 2020 Feb 10, 2021	SELL	$1.61 - $2.23 $11,200 - $15,514	-6,957 Reduced 46.87%	7,885 $15,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.51 $25,379 - $37,253	14,842 New	14,842 $37,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.